In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer
Chlorambucil (CBL) is an efficient anticancer drug. It is a lipophilic agent with serious adverse effects. The objective of this study was to formulate a CBL-loaded nanolipid carrier and target breast cancer using folic acid as a targeting probe. Characterizations of the optimum formulation were 79....
Tallennettuna:
Päätekijät: | , , , |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
Pensoft Publishers,
2022-07-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
Hyllypaikka: |
A1234.567 |
---|---|
Nide 1 | Saatavissa |